Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) EBITDA (2020 - 2025)
Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) EBITDA from Sep 30, 2020 to Dec 31, 2025. The TTM Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) EBITDA is -$7.74M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +6.17% |
| 3 Years TTM | -10.06% |
| 5 Years TTM | +67.33% |
| All Time TTM | -28.13% |
Annual EBITDA change of Anebulo Pharmaceuticals, Inc. Common Stock (ANEB)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$8.08M | +1.00% |
| 2024 | -$8M | -31.80% |
| 2023 | -$12M | +71.74% |
| 2022 | -$6.83M | -77.41% |
| 2021 | -$30M | +17688.24% |
| 2020 | -$170K | N/A |